This is the authors' abstract. We don't add key points for this paper.
Introduction: Anastomotic insufficiency after upper gastrointestinal tract surgery is associated with high morbidity and mortality. Complete pancreatectomy is representing a bail out procedure if major complications at a pancreatojejunostomy or duodenal anastomosis occured or will be expected and the patient is in a condition that does not allow for drainage or reanastomosis. Such a procedure leads to complete endo- and exocrine deficiency. Due to the lack of the insulin counter player glucagon such a state can be associated with live threatening hypoglycemia. Islet autotransplantation is a method to restore glycemic control avoiding immunosuppression. Methods: Following complete or subtotal pancreatectomy in 6 patients islets were isolated using a modified Ricordi-method. After completion of the isolation process the islets were transplanted into the liver via open surgery through a portal vein catheter infusion. Glucose, insulin and C-peptide levels were used for metabolic monitoring after autotransplantation. Result: 8 patients were autotransplanted with an average of 180.000 IEQ (110.000 – 220.000 IEQ). The autotransplantation procedure was performed without complications. 2/8 patients died during hospital stay due to septic complications with functioning autografts. 2/8 patients had a prolonged stay because of relaparotomies. The remaining two patients were treated without complications. All patients showed good primary and mid-term function of the islets. Conclusion: Islet autotransplantation is an effective tool in the treatment of pancreatectomized patients to avoid long term complications of pancreoprive diabetes.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ludwig et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: